Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
institutions such as ESO, NASA, and ONERA. This PhD in astronomical instrumentation for future space missions sits at the intersection of engineering, and astrophysics, a uniquely interdisciplinary opportunity
-
between contaminants, • the potential role of PFAS and antibiotics in the selection of antibiotic resistance genes (ARGs). The successful candidate will contribute to the development of an integrated urban
-
to solar-driven thermophotovoltaic systems. By combining numerical modeling with experimental development, this PhD aims to bridge the gap between theoretical cavity designs and practical TPV subsystem
-
such as gap solitons and synchronized arrays of photonic resonators. This PhD thesis aims to investigate both numerically and experimentally the emergence of nonlinear phenomena in a unique lattice of
-
of this project is to enhance the efficiency, sustainability, and environmental compatibility of CO2 reduction to methanol through the development of advanced catalytic materials chosen among intermetallic
-
recruitment start date. Marie Sklodowska-Curie PhDs are paid a very competitive gross salary of ~3,100 €/month, a Mobility Allowance of ~400 €/month and, for researchers who have a family, a Family Allowance of
-
funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The PhD student will be
-
belowground; - development of SDM modeling structures that best reflect plant use of multiple resources (e.g., interactive vs. substitutable resources); - testing the application of resource colimitation theory
-
-24-CE02-6823 ). • Identification of a target gene specific to Choristoneura fumiferana in mitochondrial DNA • Development of a qPCR and ddPCR protocol to quantify this target gene in sediment matrices
-
application, to ultimately benefit patients. The PhD candidate will be co-supervised by Dr. Olivier Ayrault (Children's Oncology Research Unit, Inserm U1330 / CNRS EMR 8001) and Dr. Alexandre Baffet (Cell